Periphere arterielle Verschlusskrankheit bei Diabetes mellitus

Was ist neu?

Morbidität und Mortalität. Patienten mit peripherer arterieller Verschlusskrankheit (pAVK) und Diabetes mellitus stellen eine vulnerable Patientengruppe dar. Sie weisen im Vergleich zu pAVK-Patienten ohne Diabetes eine erhöhte Morbidität und eine gesteigerte Mortalität auf.

Diabetes mellitus – ein relevanter Risikofaktor für Amputationen. Das Vorliegen eines Diabetes mellitus stellt bei Menschen mit einer pAVK ein erhebliches Risiko für eine Amputation dar. Die Inzidenz von Major-Amputationen bei Diabetikern ist nach einer aktuellen Studie 10-mal und von Minor-Amputationen 15-mal höher als bei Nichtdiabetikern. Eine Amputation bei Menschen mit Diabetes mellitus hat zudem einen erheblichen Einfluss auf die Morbidität und Mortalität.

Optimierung der Patientenversorgung notwendig. Trotz großer Anstrengungen im Gesundheitssystem repräsentiert der Diabetes mellitus weiterhin einen bedeutenden Risikofaktor, auch bei Menschen mit pAVK. Unabhängig vom Vorliegen eines Diabetes mellitus wird eine pAVK wiederum bei betroffenen Menschen oftmals nicht erkannt oder nicht adäquat therapiert. Nur wenige Menschen mit pAVK werden gefäßmedizinisch betreut. Zur Reduktion von Morbidität und Mortalität sind Prävention, frühzeitige Detektion sowie eine optimale Therapie von pAVK und Diabetes mellitus allerdings essenziell.

Abstract

Patients with peripheral artery disease and diabetes mellitus are vulnerable with an increased risk for morbidity, amputation and mortality compared to non-diabetic patients with peripheral artery disease. Despite huge efforts of the health care system diabetes mellitus still represents an important risk factor, also in people with peripheral artery disease. Regardless of the presence of diabetes mellitus people are often not aware of peripheral artery disease or do not achieve optimal therapy. Further, only few people with peripheral artery disease consult an angiologist or vascular surgeon. Aiming to reduce morbidity and mortality prevention, early detection and optimal therapy of peripheral artery disease and diabetes mellitus are crucial factors in adequate health-care management.

Schlüsselwörter

Diabetes mellitus - periphere arterielle Verschlusskrankheit - Amputation

Key words

diabetes mellitus - peripheral arterial disease - amputation

Publication History

Article published online:
01 November 2022

• Literatur

• 1 Aboyans V, Ricco JB, Bartelink MEL. et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 2018; 39: 763-816
• 2 Song P, Rudan D, Zhu Y. et al. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. The Lancet Global health 2019; 7: e1020-e1030
• 3 [Anonym]. International Diabetes Federation: IDF Diabetes Atlas. 10th ed. Brussels, Belgium: International Diabetes Federation; 2021. www.idf.org/diabetesatlas
• 4 Schmitt VH, Leuschner A, Junger C. et al. Cardiovascular profiling in the diabetic continuum: results from the population-based Gutenberg Health Study. Clinical research in cardiology: official journal of the German Cardiac Society 2022; 111: 272-283
• 5 Soyoye DO, Abiodun OO, Ikem RT. et al. Diabetes and peripheral artery disease: A review. World J Diabetes 2021; 12: 827-838
• 6 Fowkes FG, Rudan D, Rudan I. et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 2013; 382: 1329-1340
• 7 Marso SP, Hiatt WR. Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol 2006; 47: 921-929
• 8 Keller K, Schmitt VH, Vosseler M. et al. Diabetes Mellitus and Its Impact on Patient-Profile and In-Hospital Outcomes in Peripheral Artery Disease. Journal of clinical medicine 2021; 10: 5033
• 9 Luan J, Xu J, Zhong W. et al. Adverse Prognosis of Peripheral Artery Disease Treatments Associated With Diabetes: A Comprehensive Meta-Analysis. Angiology 2021;
• 10 Golledge J, Drovandi A, Rowbotham S. et al. Control of modifiable risk factors and major adverse cardiovascular events in people with peripheral artery disease and diabetes. World J Diabetes 2021; 12: 883-892
• 11 Jones WS, Patel MR, Dai D. et al. Temporal trends and geographic variation of lower-extremity amputation in patients with peripheral artery disease: results from U.S. Medicare 2000-2008. J Am Coll Cardiol 2012; 60: 2230-2236
• 12 Barnes JA, Eid MA, Creager MA. et al. Epidemiology and Risk of Amputation in Patients With Diabetes Mellitus and Peripheral Artery Disease. Arteriosclerosis, thrombosis, and vascular biology 2020; 40: 1808-1817
• 13 Chatha KK, Walsh B, La Fontaine J. et al. Lower-Extremity Amputation Trends Among People With Diabetes in a Large Urban Environment. Diabetes Care 2021; 44: e91-e92
• 14 Kamitani F, Nishioka Y, Noda T. et al. Incidence of lower limb amputation in people with and without diabetes: a nationwide 5-year cohort study in Japan. BMJ open 2021; 11: e048436
• 15 Cascini S, Agabiti N, Davoli M. et al. Survival and factors predicting mortality after major and minor lower-extremity amputations among patients with diabetes: a population-based study using health information systems. BMJ open diabetes research & care 2020; 8
• 16 Rammos C, Steinmetz M, Lortz J. et al. Peripheral artery disease in Germany (2009-2018): Prevalence, frequency of specialized ambulatory care and use of guideline-recommended therapy – A population-based study. The Lancet regional health Europe 2021; 5: 100113
• 17 Cea-Soriano L, Fowkes FGR, Johansson S. et al. Time trends in peripheral artery disease incidence, prevalence and secondary preventive therapy: a cohort study in The Health Improvement Network in the UK. BMJ open 2018; 8: e018184
• 18 Shu J, Santulli G. Update on peripheral artery disease: Epidemiology and evidence-based facts. Atherosclerosis 2018; 275: 379-381